Unichem Laboratories share news and announcements
NSE: UNICHEMLABBSE: 506690Pharmaceuticals & BiotechnologySmall Cap
Last close ₹472.95down ₹14.80 (3.03%)BSE ₹471.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹487.75.
52-week range of traded prices to 23 Oct 2026
₹278.20Low, 30 Mar 2026₹687.20High, 9 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹3,330 Cr1,036th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 10.9
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 33.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 1.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 11.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹205 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 11 Aug 2026
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.17
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 40,08440.7% delivered
Unichem Laboratories share news and announcements
717 announcements, routine notices left out, newest first. Page 13 of 15.
Oct 2011
22 Oct · Board meeting
Board of Directors of the Company in its meeting held on October 22, 2011, inter alia, allotted and issued 15,313 equity shares of Rs.2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.11 Oct · Board meeting
Inter-alia to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended September 30, 2011.
Sep 2011
Jul 2011
29 Jul · Board meeting
Board of Directors of the Company in its meeting held on July 28, 2011, inter alia, allotted and issued 4,563 equity shares of Rs.2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.14 Jul · Meeting
Annual General Meeting of the Company will be held on July 28, 2011.11 Jul · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2011.
Jun 2011
24 Jun · Business
Board of Directors of the Company in its meeting held on June 24, 2011 inter alia, allotted and issued 48,376 equity shares of Rs.2/- each pursuant to the exercise of the stock options by eligible employees under the Employee Stock Option Scheme - 2008 of the Company.
May 2011
16 May · Meeting
Company has announce the Book closure dates i.e. from July 18, 2011 to July 22, 2011 (both days inclusive), for the purpose of Annual General Meeting as well as for final dividend.16 May · Board meeting
Board of Directors of the Company at its meeting held on May 14, 2011, inter alia, considered the following:(1) Allotted and issued 3,750 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by eligible Independent Director under the Employee Stock Option Scheme - 2008 of the Company. (2) Approved and took on record the valuation report submitted by the independent valuer M/s. N A Shah Associates and fair opinion issued, by Category I Merchant Banker M/s Fedex Securities Limited and as recommended in the said valuation report, approved the share swap ratio given as under: - 4,672.552 fully paid up Equity Shares of Rs. 2/- each of the Company for every 1 (one) equity share of Rs. 100/- fully paid up each in AVM Capital Services Private Limited, - 7,843.811 fully paid up Equity Shares of Rs. 2/- each of the Company for every 1 (one) equity share of Rs. 100/- fully paid up each in Chevy Capital Services Private Limited, - 4,670,186 fully paid up Equity Shares of Rs. 2/- each of the Company for every 1 (one) equity share of Rs. 100/- fully paid up each in PM Capital Services Private Limited, - 10,936.087 fully paid up Equity Shares of Rs. 2/- each of the Company for every 1 (one) equity share of Rs, 100/- fully paid up each in Pranit Trading Private Limited and - 1,713.547 fully paid up Equity Shares of Rs. 2/- each of the Company for every 1 (one) Equity Share of Rs. 100/- each fully paid up in the Viramrut Trading Private Limited. It may be noted here that as a consequence of giving effect to the earlier amalgamation of the Second and Fourth Transferor Company i.e. Chevy Capital Services Private Limited and Pranit Trading Private Limited with the Transferee Company, the Equity Shares held by these Second and the Fourth Transferor Company in Viramrut Trading Private Limited stands extinguished and accordingly the Equity Shares of the Transferee Company are issued only to the remaining shareholders. (3) The Scheme of Arrangement shall be subject to approval of the Shareholders / Creditors of the Company, the Hon'ble High Court of Bombay and other statutory / regulatory authorities.14 May · Dividend
Board of Directors of the Company at its meeting held on May 14, 2011 has recommended Final Dividend of Rs. 2.80 (140%) per equity share of Rs. 2/- each, for the year ended March 31, 2011.5 May · Board meeting
Inter alia, to consider and take on record the Financial Results of the Company for the Quarter ended March 31, 2011 and Audited Accounts for the year ended March 31, 2011 and to recommend Final Dividend on equity shares for the Financial Year 2010-11 if any. Further, the Board shall consider the valuation report, exchange ratio and the Scheme of Arrangement between the following companies and Unichem Laboratories Limited : (1) AVM Capital Services Private Limited, (2) Chevy Capital Services Private Limited, (3) PM Capital Services Private Limited, (4) Pranit Trading Private Limited and (5) Viramrut Trading Private Limited. The above mentioned Transferor Companies are companies through which the Promoters hold shares in Unichem Laboratories Ltd. The proposed merger would help in consolidating and streamlining the Promoter holding in Unichem and bring long term stability in the holding structure of Unichem without any change in the promoter holdings.
Apr 2011
18 Apr · Business
Board of Directors of the Company in its meeting held on April 16, 2011 inter alia, allotted and issued 7,500 equity shares of Rs.2/- each pursuant to the exercise of the stock options by Non-executive Independent Directors under the Employee Stock Option Scheme-2008 of the Company.18 Apr · Board meeting
Board of Directors in its meeting held on April 16, 2011 inter alia, allotted and issued 7,500 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by Non-executive Independent Directors under the Employee Stock Option Scheme - 2008 of the Company.7 Apr · Updates
Unichem has received approval from US Food & Drug Administration (FDA) for Divalproex Sodium Delayed Release Tablets USP 125mg, 250mg and 500mg (Valproic Acid Activity). This ANDA approval will increase the presence of Unichem in US market. Unichem already has 9 other ANDA's duly approved and there are some more ANDA's in pipeline.6 Apr · Board meeting
Inter-alia, to consider and approve Annual operating plans and budget of the Company for the financial year 2011-12.
Mar 2011
8 Mar · Results
As the Company proposes to announce the Audited Financial Results for the financial year ended March 31, 2011, and therefore the Un-audited Financial Results for the last quarter ended March 31, 2011 will not be published.
Jan 2011
17 Jan · Business
Board of Directors in its meeting held on January 15, 2011 inter alia, considered the following: Allotted and issued 3,750 equity shares of Rs. 2/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.5 Jan · Board meeting
Inter-alia to consider and take on record the un-audited Financial Results of the Company for the Quarter ended December 31, 2010.
Dec 2010
Nov 2010
Oct 2010
18 Oct · Legal
Unichem Laboratories Limited had informed the Exchange that the Board of Directors in its Board Meeting held on October 16, 2010 declared an Interim Dividend of Rs. 1.20/- (60%) per equity share of Rs. 2/- (post split face value) for the year 2010-11. The Company has now informed the Exchange that percentage wise the Interim Dividend declared will remain same i.e. 60% even on Pre-Split face value of Rs. 5/- each i.e. Rs. 3/- per equity share of Rs. 5/- each. Further, dividend on fractional entitlements on account of split will be added to the proceeds arising out of sale of shares on account of such entitlements and paid to the eligible shareholders.18 Oct · Business
Board of Directors in its Board Meeting held on October 16, 2010 allotted and issued 2,300 equity shares of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company. The said shares will be issued prior to Company's record date October 22, 2010 kept for split and interim dividend.18 Oct · Dividend
Board of Directors in its Board Meeting held on October 16, 2010 declared an Interim Dividend of Rs. 1.20/- (60%) per equity share of Rs. 2/- (post split face value) for the year 2010-11.5 Oct · Corporate action
Unichem Laboratories Limited had informed the Exchange that the Board of Directors of the Company at its meeting held on September 16, 2010 has fixed October 22, 2010 as the Record date for split. The Company has now informed the Exchange that the same date (i.e. October 22, 2010) will be the record date for the purpose of payment of Interim Dividend as well. Further, November 03, 2010 has been fixed as date of payment of Interim Dividend.4 Oct · Board meeting
Inter-alia to consider and take on record the un-audited Financial Results of the Company for the Quarter ended September 30, 2010 and to consider declaration of Interim Dividend in equity shares for the year 2010-2011.
Sep 2010
23 Sep · Updates
We have been granted Certificate of suitability to European Pharmacopeia (CEP) by European Directorate for the Quality of Medicines and Healthcare (EDQM) for Alfuzosin Hydrochloride17 Sep · Corporate action
Board of Directors of the Company at its meeting held on September 16, 2010 transacted the following business: 1) Fixed October 22, 2010 as the Record date for the purpose of ascertaining the names of the shareholders who would be entitled to receive equity shares of Rs.2/- for existing shares of Rs.5/- each held by them as on the said Record Date; 2) Allotted 400 equity shares of Rs.5/- under Employee Stock Option Scheme - 2008.8 Sep · Board meeting
To consider inter alia Record Date for sub-division of face value and allotment of shares under Employee Stock Option Scheme - 2008.
Aug 2010
3 Aug · Updates
The Company has received ANDA approval from the United States Food and Drug Administration (U.S.FDA) for Bisoprolol & Hydrochlorothiazide Tablets. The product will be now immediately commercialized from Unichem's Goa Plant. Active pharmaceutical ingredient i.e. Bisoprolol & Hydrochlorothiazide used for this ANDA is also made in-house at Roha plant Unichem has 8 other ANDA's duly approved
Jul 2010
22 Jul · Meeting
Board of Directors of the Company have decided to close the Register of Members and Share Transfer Books of the Company from September 13, 2010 to September 15, 2010 (both days inclusive), for the purpose of Annual General Meeting, which is to be held on September 16, 2010.22 Jul · Board meeting
Board of Directors in its meeting held on July 22, 2010, inter alia, considered the following : (1) Allotted and issued 800 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company, and; (2) Allotted and issued 22,000 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2008 of the Company.22 Jul · Share Split
Board of Directors of the Company in its meeting held on July 22, 2010, have approved the proposal to sub-divide the nominal value of the equity shares of the Company from Rs.5/- each to the nominal value of Rs.2/- each, subject to the approval of the Members at the Annual General Meeting (AGM) of the Company.12 Jul · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the Company for the Quarter ended June 30, 2010. The Board may also consider a proposal to sub-divide the equity shares of Rs.5/- each of the Company into such denomination as the Board may deem appropriate , subject to the approval of the shareholders at the ensuing Annual General Meeting.
Jun 2010
29 Jun · Change of E-mail ID for Investors' Grievance Redressal
Due to change in our domain name, there is change in the email address designated for the purpose of registering complaints by the investors. The following is the new email address: [email protected]
May 2010
11 May · Business
Board of Directors of the Company at its Meeting held on May 10, 2010, allotted and issued 2,800 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme - 2004 of the Company.10 May · Business
Board of Directors of the Company at its Meeting held on May 10, 2010, allotted and issued 3,000 equity shares of Rs.5/- each pursuant to the exercise of the stock options by the eligible employees under the Employee Stock Option Scheme-2008 of the Company.10 May · Dividend
Board of Directors of the Company at its Meeting held on May 10, 2010 declared 2nd Interim dividend of Rs.7/- (140%) per equity share of Rs.5/- for the year 2009-2010.
Apr 2010
23 Apr · Board meeting
To consider Unaudited financial results for the quarter ended March 31, 2010. Further the meeting may also consider declaration of 2nd Interim Dividend on equity shares for the year 2009-2010. Further May 17, 2010 has been fixed as Record Date for the purpose of payment of Interim Dividend and May 21, 2010 has been fixed as date of payment of Interim Dividend, if declared in the said meeting.